Omega Therapeutics Inc. (NASDAQ: OMGA)
$2.09
+0.1350 ( +6.92% ) 360.7K
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. ItĀ operates in the U.S.
Market Data
Open
$2.09
Previous close
$1.95
Volume
360.7K
Market cap
$115.27M
Day range
$1.98 - $2.14
52 week range
$1.30 - $6.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | May 31, 2024 |
3 | Insider transactions | 2 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
8-k/a | 8K-related | 11 | May 30, 2024 |
8-k | 8K-related | 11 | May 30, 2024 |
8-k | 8K-related | 13 | May 06, 2024 |
10-q | Quarterly Reports | 89 | May 06, 2024 |
def | Proxies and info statements | 11 | Apr 29, 2024 |
pre | Proxies and info statements | 8 | Apr 19, 2024 |
8-k | 8K-related | 11 | Apr 16, 2024 |